8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 18, 2025 · 1y ago · Accession 0001628280-25-032155
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 1662579
- Form type
- 8-K
- Filing date
- Jun 18, 2025
- Report date
- Jun 18, 2025
- Document
- cccc-20250618.htm
- Size
- 455 KB